|
||
|
30-day mortality. |
|
||||||||
| Part of: Kyuchukov D, Zheleva-Kyuchukova I, Nachev G (2020) Antithrombotic regimens in patients after coronary artery bypass grafting and coronary endarterectomy. Pharmacia 67(3): 115-120. https://doi.org/10.3897/pharmacia.67.e52738 |